These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


413 related items for PubMed ID: 12112963

  • 1. Recombinant gonadotropins.
    Lathi RB, Milki AA.
    Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
    [Abstract] [Full Text] [Related]

  • 2. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
    Antoine JM, Loumaye E, Alvarez S, Merviel P, Cornet D, Mandelbaum J, Salat-Baroux J.
    Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
    [Abstract] [Full Text] [Related]

  • 3. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R, Buckler HM, Matson P, Lieberman B, Burger HG, Hilton B, Horne G, Dyson M, Robertson WR.
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
    Cheon KW, Byun HK, Yang KM, Song IO, Choi KH, Yoo KJ.
    J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
    [Abstract] [Full Text] [Related]

  • 5. Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology.
    Baer G, Loumaye E.
    Curr Med Res Opin; 2003 Sep; 19(2):83-8. PubMed ID: 12740151
    [Abstract] [Full Text] [Related]

  • 6. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N, Persico P, Di Sebastiano F, Marsiglio E, Ferrari A.
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [Abstract] [Full Text] [Related]

  • 7. Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations.
    Loutradis D, Elsheikh A, Kallianidis K, Drakakis P, Stefanidis K, Milingos S, Michalas S.
    Arch Gynecol Obstet; 2004 Dec; 270(4):223-6. PubMed ID: 13680266
    [Abstract] [Full Text] [Related]

  • 8. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 9. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation.
    De Placido G, Alviggi C, Mollo A, Strina I, Ranieri A, Alviggi E, Wilding M, Varricchio MT, Borrelli AL, Conforti S.
    Clin Endocrinol (Oxf); 2004 May; 60(5):637-43. PubMed ID: 15104569
    [Abstract] [Full Text] [Related]

  • 10. Gonadotropins in the treatment of infertility.
    Butt WR.
    Acta Endocrinol Suppl (Copenh); 1988 May; 288():51-7. PubMed ID: 3138866
    [Abstract] [Full Text] [Related]

  • 11. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S, Spanish Collaborative Group on Female Hypogonadotrophic Hypogonadism.
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [Abstract] [Full Text] [Related]

  • 12. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
    De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A, Italian Collaborative Group on Recombinant Human Luteinizing Hormone.
    Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
    [Abstract] [Full Text] [Related]

  • 13. [Recent progress in the hormonal treatment of sterility].
    Fanard A.
    Brux Med; 1975 Jul; 55(7):401-14. PubMed ID: 1098749
    [Abstract] [Full Text] [Related]

  • 14. Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens.
    Casadei L, Zamaro V, Calcagni M, Ticconi C, Dorrucci M, Piccione E.
    Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):155-61. PubMed ID: 16687201
    [Abstract] [Full Text] [Related]

  • 15. Ovulation induction: a mini review.
    Messinis IE.
    Hum Reprod; 2005 Oct; 20(10):2688-97. PubMed ID: 16006478
    [Abstract] [Full Text] [Related]

  • 16. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S, Fedorcsak P, Abyholm T, Storeng R, Ertzeid G, Oldereid N, Omland A, Tanbo T.
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [Abstract] [Full Text] [Related]

  • 17. Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization.
    Meden-Vrtovec H, Mocnik-Roznik S, Tomazevic T, Virant-Klun I.
    J Reprod Med; 2003 Oct; 48(10):799-803. PubMed ID: 14619648
    [Abstract] [Full Text] [Related]

  • 18. Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating hormone or highly purified human menopausal gonadotropin.
    Grøndahl ML, Borup R, Lee YB, Myrhøj V, Meinertz H, Sørensen S.
    Fertil Steril; 2009 May; 91(5):1820-30. PubMed ID: 18439596
    [Abstract] [Full Text] [Related]

  • 19. Ovulation induction.
    Marshall JR.
    Obstet Gynecol; 1970 Jun; 35(6):963-70. PubMed ID: 4911159
    [No Abstract] [Full Text] [Related]

  • 20. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
    Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN.
    Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.